Deborah Persaud, MD

CRS:

JHU

Role:

Investigators

Position:

Co-investigator

A clinician and researcher specializing in the study and treatment of  HIV-1 infection in children, Deborah Persaud directors the pediatric infectious diseases fellowship program at Hopkins Children’s. A 1985 graduate of the New York University School of Medicine, she trained in pediatrics at Babies Hospital/ Columbia Presbyterian Medical Center in New York, where she was chief resident. She was an infectious disease fellow, an Aaron Diamond Post Doctoral Research Fellow and a faculty member at New York University. She joined Johns Hopkins’ faculty in 1997 following a visiting lectureship at the Moi University, Eldoret, Kenya.

  • Member, Immune Activation Focus Group of Inflammation TSG
  • External Investigator Appointed, HIV Reservoirs and Viral Eradication Transformative Science Group
  • Chair, IMPAACT HIV CURE Scientific Committee

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P1060:  Phase II, parallel, randomized, clinical trials...

A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...

Read More

NWCS 414, Evaluation of a Serum Biosignature for Identifying...

We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

A5332: Randomized Trial to Prevent Vascular Events in HIV...

REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....

Read More

A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment...

A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...

Read More